Astrotech (NASDAQ:ASTC) Issues Earnings Results

Astrotech (NASDAQ:ASTC) released its earnings results on Wednesday. The aerospace company reported ($2.25) EPS for the quarter, FiscalAI reports. Astrotech had a negative return on equity of 68.53% and a negative net margin of 1,163.89%.The firm had revenue of $0.34 million for the quarter.

Astrotech Stock Performance

ASTC traded down $0.01 during trading on Wednesday, reaching $2.69. 15,891 shares of the company traded hands, compared to its average volume of 1,396,745. Astrotech has a 12-month low of $1.91 and a 12-month high of $8.01. The firm has a fifty day simple moving average of $3.04 and a 200 day simple moving average of $3.30. The company has a market cap of $4.73 million, a P/E ratio of -0.32 and a beta of -0.25.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Astrotech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, April 24th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Susquehanna International Group LLP purchased a new position in shares of Astrotech in the third quarter valued at $66,000. DRW Securities LLC grew its holdings in shares of Astrotech by 168.5% in the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after purchasing an additional 19,747 shares in the last quarter. Finally, J. Safra Sarasin Holding AG purchased a new position in shares of Astrotech in the first quarter valued at $140,000. 24.35% of the stock is owned by hedge funds and other institutional investors.

About Astrotech

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.